Outcome in 212 anti‐Ro/SSA‐positive pregnancies and population‐based incidence of congenital heart block
Identifieur interne : 000D98 ( Main/Exploration ); précédent : 000D97; suivant : 000D99Outcome in 212 anti‐Ro/SSA‐positive pregnancies and population‐based incidence of congenital heart block
Auteurs : Amanda Skog [Suède] ; Linda Lagnefeldt [Suède] ; Peter Conner [Suède] ; Marie Wahren-Herlenius [Suède] ; Sven-Erik Sonesson [Suède]Source :
- Acta Obstetricia et Gynecologica Scandinavica [ 0001-6349 ] ; 2016-01.
Abstract
Introduction: We investigated the effects of maternal autoimmune disease and fetal congenital heart block (CHB) on pregnancy outcomes in anti‐Ro/SSA‐positive women and assessed the population‐based incidence of isolated CHB. Material and methods: One hundred and ninety nine anti‐Ro/SSA‐positive pregnancies were prospectively followed at our center (2000–2013). Seven fetuses developed atrioventricular block (AVB) II–III. In this period, another 13 anti‐Ro/SSA‐positive pregnancies were referred for fetal bradycardia, subsequently diagnosed with AVB II–III. Cesarean section rates, gestational age, body measurements at birth, and the incidence of CHB in these 212 pregnancies were analyzed in relation to fetal atrioventricular conduction and maternal diagnosis and compared with data from the Medical Birth Registry on 352 104 pregnancies in the Stockholm County. Results: The prevalence of maternal systemic lupus erythematosus (SLE) and primary Sjögren's syndrome and the outcomes at birth were similar in normal conduction and AVB I cases. Only 1/20 AVB II–III cases (0/7 in the surveillance group) had a mother diagnosed with SLE, compared with 73/192 in cases with normal conduction or AVB I. Excluding cases with AVB II–III, SLE mothers more frequently delivered by cesarean section (31% vs. 20%, p < 0.05) and had a higher incidence of preterm birth (13% vs. 5.8%, p < 0.05) than the county population. Both SLE and primary Sjögren's syndrome mothers had a fourfold greater rate of growth‐retarded babies (10.11% vs. 2.2%, p < 0.001). The incidence of autoantibody‐related AVB II–III in Stockholm County was 1/23 300. Conclusion: This study of CHB provides new information on the incidence of CHB and outcome of pregnancy in anti‐Ro/SSA‐positive women, which has clinical relevance when counseling rheumatic patients considering pregnancy.
Url:
DOI: 10.1111/aogs.12785
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001358
- to stream Istex, to step Curation: 001358
- to stream Istex, to step Checkpoint: 000017
- to stream Main, to step Merge: 000D99
- to stream Main, to step Curation: 000D98
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Outcome in 212 anti‐Ro/SSA‐positive pregnancies and population‐based incidence of congenital heart block</title><author><name sortKey="Skog, Amanda" sort="Skog, Amanda" uniqKey="Skog A" first="Amanda" last="Skog">Amanda Skog</name></author><author><name sortKey="Lagnefeldt, Linda" sort="Lagnefeldt, Linda" uniqKey="Lagnefeldt L" first="Linda" last="Lagnefeldt">Linda Lagnefeldt</name></author><author><name sortKey="Conner, Peter" sort="Conner, Peter" uniqKey="Conner P" first="Peter" last="Conner">Peter Conner</name></author><author><name sortKey="Wahren Erlenius, Marie" sort="Wahren Erlenius, Marie" uniqKey="Wahren Erlenius M" first="Marie" last="Wahren-Herlenius">Marie Wahren-Herlenius</name></author><author><name sortKey="Sonesson, Sven Rik" sort="Sonesson, Sven Rik" uniqKey="Sonesson S" first="Sven-Erik" last="Sonesson">Sven-Erik Sonesson</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:C42A038E03B3383BD751462F4316D97F1B69F030</idno><date when="2016" year="2016">2016</date><idno type="doi">10.1111/aogs.12785</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-Q9RSMHJ4-J/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001358</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001358</idno><idno type="wicri:Area/Istex/Curation">001358</idno><idno type="wicri:Area/Istex/Checkpoint">000017</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000017</idno><idno type="wicri:doubleKey">0001-6349:2016:Skog A:outcome:in:anti</idno><idno type="wicri:Area/Main/Merge">000D99</idno><idno type="wicri:Area/Main/Curation">000D98</idno><idno type="wicri:Area/Main/Exploration">000D98</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Outcome in 212 anti‐Ro/SSA‐positive pregnancies and population‐based incidence of congenital heart block</title><author><name sortKey="Skog, Amanda" sort="Skog, Amanda" uniqKey="Skog A" first="Amanda" last="Skog">Amanda Skog</name><affiliation wicri:level="3"><country xml:lang="fr">Suède</country><wicri:regionArea>Unit of Experimental Rheumatology, Department of Medicine, Karolinska Institute, Stockholm</wicri:regionArea><placeName><settlement type="city">Stockholm</settlement><region nuts="2">Svealand</region></placeName></affiliation><affiliation></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Suède</country></affiliation></author><author><name sortKey="Lagnefeldt, Linda" sort="Lagnefeldt, Linda" uniqKey="Lagnefeldt L" first="Linda" last="Lagnefeldt">Linda Lagnefeldt</name><affiliation wicri:level="3"><country xml:lang="fr">Suède</country><wicri:regionArea>Pediatric Cardiology Unit, Department of Women's and Children's Health, Karolinska Institute, Stockholm</wicri:regionArea><placeName><settlement type="city">Stockholm</settlement><region nuts="2">Svealand</region></placeName></affiliation></author><author><name sortKey="Conner, Peter" sort="Conner, Peter" uniqKey="Conner P" first="Peter" last="Conner">Peter Conner</name><affiliation wicri:level="3"><country xml:lang="fr">Suède</country><wicri:regionArea>Division of Obstetrics and Gynecology, Department of Women's and Children's Health, Karolinska Institute, Stockholm</wicri:regionArea><placeName><settlement type="city">Stockholm</settlement><region nuts="2">Svealand</region></placeName></affiliation></author><author><name sortKey="Wahren Erlenius, Marie" sort="Wahren Erlenius, Marie" uniqKey="Wahren Erlenius M" first="Marie" last="Wahren-Herlenius">Marie Wahren-Herlenius</name><affiliation wicri:level="3"><country xml:lang="fr">Suède</country><wicri:regionArea>Unit of Experimental Rheumatology, Department of Medicine, Karolinska Institute, Stockholm</wicri:regionArea><placeName><settlement type="city">Stockholm</settlement><region nuts="2">Svealand</region></placeName></affiliation></author><author><name sortKey="Sonesson, Sven Rik" sort="Sonesson, Sven Rik" uniqKey="Sonesson S" first="Sven-Erik" last="Sonesson">Sven-Erik Sonesson</name><affiliation wicri:level="3"><country xml:lang="fr">Suède</country><wicri:regionArea>Pediatric Cardiology Unit, Department of Women's and Children's Health, Karolinska Institute, Stockholm</wicri:regionArea><placeName><settlement type="city">Stockholm</settlement><region nuts="2">Svealand</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Acta Obstetricia et Gynecologica Scandinavica</title><title level="j" type="alt">ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA</title><idno type="ISSN">0001-6349</idno><idno type="eISSN">1600-0412</idno><imprint><biblScope unit="vol">95</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="98">98</biblScope><biblScope unit="page" to="105">105</biblScope><biblScope unit="page-count">8</biblScope><date type="published" when="2016-01">2016-01</date></imprint><idno type="ISSN">0001-6349</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0001-6349</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">Introduction: We investigated the effects of maternal autoimmune disease and fetal congenital heart block (CHB) on pregnancy outcomes in anti‐Ro/SSA‐positive women and assessed the population‐based incidence of isolated CHB. Material and methods: One hundred and ninety nine anti‐Ro/SSA‐positive pregnancies were prospectively followed at our center (2000–2013). Seven fetuses developed atrioventricular block (AVB) II–III. In this period, another 13 anti‐Ro/SSA‐positive pregnancies were referred for fetal bradycardia, subsequently diagnosed with AVB II–III. Cesarean section rates, gestational age, body measurements at birth, and the incidence of CHB in these 212 pregnancies were analyzed in relation to fetal atrioventricular conduction and maternal diagnosis and compared with data from the Medical Birth Registry on 352 104 pregnancies in the Stockholm County. Results: The prevalence of maternal systemic lupus erythematosus (SLE) and primary Sjögren's syndrome and the outcomes at birth were similar in normal conduction and AVB I cases. Only 1/20 AVB II–III cases (0/7 in the surveillance group) had a mother diagnosed with SLE, compared with 73/192 in cases with normal conduction or AVB I. Excluding cases with AVB II–III, SLE mothers more frequently delivered by cesarean section (31% vs. 20%, p < 0.05) and had a higher incidence of preterm birth (13% vs. 5.8%, p < 0.05) than the county population. Both SLE and primary Sjögren's syndrome mothers had a fourfold greater rate of growth‐retarded babies (10.11% vs. 2.2%, p < 0.001). The incidence of autoantibody‐related AVB II–III in Stockholm County was 1/23 300. Conclusion: This study of CHB provides new information on the incidence of CHB and outcome of pregnancy in anti‐Ro/SSA‐positive women, which has clinical relevance when counseling rheumatic patients considering pregnancy.</div></front></TEI><affiliations><list><country><li>Suède</li></country><region><li>Svealand</li></region><settlement><li>Stockholm</li></settlement></list><tree><country name="Suède"><region name="Svealand"><name sortKey="Skog, Amanda" sort="Skog, Amanda" uniqKey="Skog A" first="Amanda" last="Skog">Amanda Skog</name></region><name sortKey="Conner, Peter" sort="Conner, Peter" uniqKey="Conner P" first="Peter" last="Conner">Peter Conner</name><name sortKey="Lagnefeldt, Linda" sort="Lagnefeldt, Linda" uniqKey="Lagnefeldt L" first="Linda" last="Lagnefeldt">Linda Lagnefeldt</name><name sortKey="Skog, Amanda" sort="Skog, Amanda" uniqKey="Skog A" first="Amanda" last="Skog">Amanda Skog</name><name sortKey="Sonesson, Sven Rik" sort="Sonesson, Sven Rik" uniqKey="Sonesson S" first="Sven-Erik" last="Sonesson">Sven-Erik Sonesson</name><name sortKey="Wahren Erlenius, Marie" sort="Wahren Erlenius, Marie" uniqKey="Wahren Erlenius M" first="Marie" last="Wahren-Herlenius">Marie Wahren-Herlenius</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D98 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D98 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:C42A038E03B3383BD751462F4316D97F1B69F030
|texte= Outcome in 212 anti‐Ro/SSA‐positive pregnancies and population‐based incidence of congenital heart block
}}
| This area was generated with Dilib version V0.6.33. |  |